Skip to main content
HUAPONT LIFE SCIENCES CO., LTD. logo

HUAPONT LIFE SCIENCES CO., LTD. — Investor Relations & Filings

Ticker · 002004 ISIN · CNE000001JJ6 LEI · 3003009TGXJC0JJVTJ07 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,461 across all filing types
Latest filing 2024-06-03 Transaction in Own Shar…
Country CN China
Listing Shenzhen Stock Exchange 002004

About HUAPONT LIFE SCIENCES CO., LTD.

https://www.huapont.com.cn

HUAPONT LIFE SCIENCES CO., LTD. operates as a diversified entity specializing in the research, development, manufacturing, and distribution of pharmaceutical and chemical solutions. The company holds a prominent position in the dermatology sector, providing a comprehensive range of therapeutic products for various skin disorders. Its pharmaceutical operations extend to the production of high-quality active pharmaceutical ingredients (APIs) and finished dosage forms. Beyond human health, the organization maintains a significant footprint in the agrochemical sector, focusing on the development and supply of crop protection products, including herbicides and pesticides. The company also integrates healthcare services into its business model, overseeing the operation of medical facilities and specialized clinics. Its strategic focus centers on technological advancement and the maintenance of a robust supply chain to support its global commercial activities.

Recent filings

Filing Released Lang Actions
关于回购公司股份的进展公告
Transaction in Own Shares Classification · 100% confidence The document is a progress announcement regarding the company's share repurchase plan. It details the number of shares repurchased, prices, total amount spent, compliance with regulatory rules, and future intentions to continue the buyback. It references prior announcements about the repurchase plan and dividend distribution but does not contain financial statements or earnings data. The document is short (1428 characters) and focuses on the update of the share buyback activity, which fits the definition of a Transaction in Own Shares (POS) filing rather than a full financial report or other categories.
2024-06-03 Chinese
2023年度权益分派实施公告
Notice of Dividend Amount Classification · 100% confidence The document is titled as an "Implementation Announcement of the 2023 Annual Equity Distribution" by Huabang Life Health Co., Ltd. It details the dividend distribution plan approved at the 2023 Annual General Meeting held on May 23, 2024, including dividend amounts, record dates, ex-dividend dates, and related procedural information. The text explicitly states that the dividend plan was approved at the annual shareholders meeting and now the company is announcing the implementation details of the dividend payment. The document is relatively short (2811 characters) and focuses on the announcement of the dividend distribution rather than the full annual report or financial statements. It does not contain comprehensive financial data or management discussion but rather the specifics of the dividend payment. Therefore, this document fits the category of "Notice of Dividend Amount" (DIV), which covers announcements of dividend amounts, payment dates, and details for shareholders.
2024-05-27 Chinese
2023年年度股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is titled as a resolution announcement from the 2023 Annual General Meeting (AGM) of Huabang Life Health Co., Ltd. It details the meeting attendance, voting results on various agenda items including the 2023 annual report, financial statements, profit distribution plan, and appointment of auditors. The document includes legal opinions confirming the validity of the meeting and voting procedures. The content is focused on the official voting results and resolutions passed at the AGM rather than the full annual report or financial statements themselves. The document length is relatively short (2336 characters) and it serves as an official announcement of the AGM resolutions and voting outcomes. Therefore, it fits best under the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2024-05-23 Chinese
2023年年度股东大会法律意见书
AGM Information Classification · 95% confidence The document is a legal opinion letter from a law firm regarding the 2023 Annual General Meeting (AGM) of Huabang Life Health Co., Ltd. It details the convening, attendance, voting procedures, and results of the AGM. The document does not contain the actual annual report or financial statements but rather confirms the legality and validity of the AGM process and its resolutions. This type of document is typically associated with AGM Information filings, as it supports the materials shared or related to the AGM rather than being a standalone financial report or voting result announcement. The document length is 4677 characters, which is consistent with a detailed legal opinion letter rather than a brief announcement. Therefore, the most appropriate classification is AGM Information (AGM-R).
2024-05-23 Chinese
关于回购公司股份的进展公告
Transaction in Own Shares Classification · 100% confidence The document is a progress announcement regarding the company's share repurchase plan. It details the number of shares repurchased, prices, total amount spent, compliance with regulatory rules, and future intentions to continue the buyback. It references prior announcements about the share repurchase plan but does not contain financial statements or earnings data. The document length is short (1226 characters) and focuses on the update of the share buyback activity. Therefore, it fits the category of a Transaction in Own Shares (POS) filing, which covers reports of the company buying back its own shares.
2024-05-06 Chinese
关于召开2023年度业绩网上说明会的公告
Investor Presentation Classification · 95% confidence The document is an announcement about a 2023 annual performance online briefing (业绩说明会) scheduled for April 29, 2024. It references that the 2023 Annual Report has already been disclosed on April 27, 2024, and invites investors to participate in the online meeting to discuss the annual results. The document does not contain the actual annual report or detailed financial data but rather serves as an invitation and information about the upcoming investor presentation event. Therefore, it is best classified as an Investor Presentation (IP) announcement rather than the Annual Report (10-K) itself or a Report Publication Announcement (RPA). The document length is short and focused on the event details and investor engagement, consistent with an Investor Presentation notice.
2024-04-26 Chinese

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.